Clinical Trial Update: H-IVIG Treatment for Severe H1N1 2009 [NA]

View source ↗

Summary

A completed clinical trial evaluated H-IVIG for severe H1N1 influenza infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Virus Infection H1n1 Subtype

Drugs mentioned

• H-IVIG (Hyperimmune intravenous immunoglobulin)

Snippet

Sponsor: The University of Hong Kong | Conditions: Novel 2009 Influenza A (H1N1) Infection | NA | Status: COMPLETED